LSE – When Will Dr. Martens IPO in 2021 and What Can Investors Expect?

Dr. Martens could have a valuation of about $4 billion or 3 billion pounds, according to MarketWatch. Currently, the company sells about 11 million pairs of shoes and boots annually in over 60 countries.  

The British footwear company saw a severe drop in sales revenue early in 2000, which led to some factory closures. However, in 2014, Permira acquired the brand for about $400 million. Since then, the company’s sales have increased substantially. Dr. Martens went from $220 million in revenue in 2014 to over $900 million in revenue in the year ending March 2020, according to NPR.  

Permira has brought growth to the company through investing in e-commerce, which represented 30 percent of its total revenue in the nine months ending Dec. 31, 2020, according to MarketWatch. Even though most stores were closed during the COVID-19 pandemic, the company’s revenue increased for the six-month period ending September 30, 2020, compared to the same period in 2019.